(Q36115657)

12 August 2017

1 reference

title

Treatment of metastatic malignant melanoma. (English)

1 reference

12 August 2017

Ehab Atallah

1

1 reference

PubMed ID

15869730

12 August 2017

Lawrence Flaherty

series ordinal

2

1 reference

12 August 2017

1 May 2005

1 reference

Current Treatment Options in Oncology

12 August 2017

1 reference

12 August 2017

6

1 reference

12 August 2017

185-193

1 reference

12 August 2017

3

1 reference

https://scigraph.springernature.com/pub.10.1007/s11864-005-0002-5

12 August 2017

0 references

cites work

Management of brain metastases in patients with melanoma

1 reference

12 December 2020

Dacarbazine, cisplatin and carmustine, with or without tamoxifen, for metastatic melanoma: 5-year follow-up.

1 reference

12 December 2020

Surgical therapy for distant metastases of malignant melanoma

1 reference

12 December 2020

Gamma knife radiosurgery for metastatic melanoma: an analysis of survival, outcome, and complications

1 reference

12 December 2020

Cancer statistics, 2004

1 reference

12 December 2020

Phase III multicenter randomized trial of the Dartmouth regimen versus dacarbazine in patients with metastatic melanoma

1 reference

12 December 2020

Isolated limb infusion for melanoma: a simple but effective alternative to isolated limb perfusion.

1 reference

12 December 2020

WR-2721 and high-dose cisplatin: an active combination in the treatment of metastatic melanoma.

1 reference

12 December 2020

Sequential biochemotherapy versus chemotherapy for metastatic melanoma: results from a phase III randomized trial.

1 reference

12 December 2020

Guidelines for the safe administration of high-dose interleukin-2.

1 reference

12 December 2020

Phase III trial of dacarbazine versus dacarbazine with interferon alpha-2b versus dacarbazine with tamoxifen versus dacarbazine with interferon alpha-2b and tamoxifen in patients with metastatic malignant melanoma: an Eastern Cooperative Oncology Gr

1 reference

12 December 2020

A prospective evaluation of a triple-drug regimen containing cisplatin, vinblastine, and dacarbazine (CVD) for metastatic melanoma

1 reference

12 December 2020

High-dose recombinant interleukin 2 therapy for patients with metastatic melanoma: analysis of 270 patients treated between 1985 and 1993

1 reference

12 December 2020

Phase II study of temozolomide plus thalidomide for the treatment of metastatic melanoma

1 reference

12 December 2020

Phase II randomized trial of cisplatin and WR-2721 versus cisplatin alone for metastatic melanoma: an Eastern Cooperative Oncology Group Study (E1686).

1 reference

12 December 2020

The role of taxanes in the treatment of metastatic melanoma

1 reference

12 December 2020

Prognostic factors in 1,521 melanoma patients with distant metastases.

1 reference

12 December 2020

Metastasectomy for recurrent stage IV melanoma

1 reference

12 December 2020

Isolated limb perfusion for malignant melanoma

1 reference

12 December 2020

Cancer Research Campaign phase II trial of temozolomide in metastatic melanoma

1 reference

12 December 2020

Cisplatin hydration with and without mannitol diuresis in refractory disseminated malignant melanoma: a southwest oncology group study

1 reference

12 December 2020

Randomized phase III study of temozolomide versus dacarbazine in the treatment of patients with advanced metastatic malignant melanoma

1 reference

12 December 2020

Prolonged survival of 2 years or longer for patients with disseminated melanoma. An analysis of related prognostic factors.

1 reference

12 December 2020

Cancer regression in patients with metastatic melanoma after the transfer of autologous antitumor lymphocytes

1 reference

12 December 2020

Metastatic melanoma: chemotherapy

1 reference

12 December 2020

The role of interferon alfa in the treatment of metastatic melanoma

1 reference

12 December 2020

Management of cutaneous melanoma

1 reference

12 December 2020

10.1007/S11864-005-0002-5

Identifiers

DOI

1 reference

12 August 2017

1 reference

PubMed ID

15869730